Key Takeaway: HeartSciences presented its MyoVista wavECG Technology at the UN General Assembly during the 4th Annual International Digital Health Symposium in New York City. COO Mark Hilz showcased the MyoVista device through a live lab demonstration, highlighting its innovative features. This opportunity underscores the importance of digital health solutions on a global platform.
Price reaction · baseline $4.8861 (2024-09-26T17:13:00.000Z) · hit during market hours · clean, no other HSCS news in the window
day 0 close · peak
-0.3%
Market Sentiment Analysis
POSITIVE FACTORS
HeartSciences showcased innovative technology at a prestigious event.
The presentation was part of a significant international health symposium.
Live lab demonstrations enhance visibility and credibility of the MyoVista device.
Full Press Release Details
HeartSciences had a unique opportunity to showcase our MoVista® wav ECG™ Technology during the UN General Assembly on Wednesday September 25 th . Mark Hilz (COO) also presented the MyoVista wav ECG Device as part of the 4th Annual International Digital Health Symposium live lab demonstration.
Frequently Asked Questions
What technology did HeartSciences present?
HeartSciences showcased the MyoVista wavECG Technology.
Where was the MyoVista device presented?
It was presented at the UN General Assembly in New York City.
Who presented the MyoVista device?
Mark Hilz, the COO of HeartSciences, presented the device.
What event featured the MyoVista demonstration?
The demonstration was part of the 4th Annual International Digital Health Symposium.